Lantheus Holdings, Inc.
Known title: 10% OwnerCIK: 0001521036
Associated companies
Transaction History
| CATX | ▼ Sell | Open Market | 35,769 | $112K | 9/1/2026 | View on chart |
| CATX | ▼ Sell | Open Market | 78,145 | $246K | 8/31/2026 | View on chart |
| CATX | ▼ Sell | Open Market | 35,769 | $112K | 9/1/2026 | View on chart |
| CATX | ▼ Sell | Open Market | 78,145 | $246K | 8/31/2026 | View on chart |
We use analytics to understand how market-wall is used. No personal data is sold.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 26, 2026
CATX included in pre-market movers list
Perspective Therapeutics was listed among stocks moving lower in Monday's pre-market session. The company is currently trading near its 52-week low, with an RSI of 32.3 indicating oversold conditions. Analysts maintain an average price target of $12.29, which is significantly higher than the current market price.
CATX included in pre-market movers list. Perspective Therapeutics was listed among stocks moving lower in Monday's pre-market session. The company is currently trading near its 52-week low, with an RSI of 32.3 indicating oversold conditions. Analysts maintain an average price target of $12.29, which is significantly higher than the current market price.